Oxcarbazepine Api Powder, USP

Oxcarbazepine API (CAS No. 28721‑07‑5) is a high‑purity anticonvulsant Active Pharmaceutical Ingredient widely used in formulations for epilepsy and seizure management. It is primarily indicated for the control and prevention of partial‑onset seizures in both adults and pediatric populations. Oxcarbazepine can be used as: Monotherapy (stand‑alone treatment) Adjunct therapy in combination with other antiepileptic agents While its primary use is in epilepsy management, Oxcarbazepine is also used in some regulated formulations for neuropathic conditions, including trigeminal neuralgia, and in certain mood‑stabilization protocols (as per clinical supervision). Oxcarbazepine is highly valued for its excellent safety profile, predictable pharmacokinetics, and broad clinical utility. Specifications & Details - Product Name: Oxcarbazepine - Synonyms: 10,11‑Dihydro‑10‑oxo‑5H‑dibenz(b,f)azepine‑5‑carboxamide - Product Code: ATM024OXCB - Grade: USP / EP / BP - CAS Number: 28721‑07‑5 - Molecular Formula: C15H12N2O2 - Molecular Weight: 252.27 g/mol - COA & MSDS: Available on request Packaging: 25 Kg HDPE drums with double liner bags Storage Condition: Store in air‑tight containers Protect from light and moisture Key Features Manufactured in WHO‑GMP compliant facilities High‑purity CNS‑active anticonvulsant API Low impurity profile and excellent stability Suitable for tablets, film‑coated tablets, and oral suspensions Export‑grade material with batch‑wise consistency Full regulatory documentation (COA, MSDS, technical dossier) Applications Used in pharmaceutical formulations for: Partial‑onset seizure management Adjunct antiepileptic therapy Pediatric and adult epilepsy treatment Neuropathic‑pain-related formulations (e.g., trigeminal neuralgia) Mood‑stabilizing formulations (as per regulatory guidelines) Oxcarbazepine API, Anticonvulsant Bulk Drug, Epilepsy Treatment Ingredient, Partial‑Onset Seizure API, CNS Active Pharmaceutical Ingredient, Neuropathic Pain API, CAS 28721‑07‑5, USP Grade, EP Grade, BP Grade, WHO‑GMP Certified, Pharmaceutical Export. #Oxcarbazepine #PharmaceuticalAPI #Anticonvulsant #EpilepsyAPI #NeuropathicPain #BulkDrugs #ActiveIngredient #PharmaExport #CAS28721075 #USPGrade #EPGrade #BPGrade About the Company GST Registration Date: 2020 Legal Status of Firm: Proprietorship Number of Employees: 11 To 25 People Annual Turnover: 40 L - 1.5 Cr